CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Walbert Timothy P Director | Grant or award | +3,130 | 3,130 | ||
| 2025-02-24 | Burkhart Erin GVP, Chief Accounting Officer | Sale 10b5-1 | −1,344 | $68.38 | $92K | 13,105 |
| 2024-11-29 | Hardy Alexander Chief Executive Officer | Shares withheld for taxes | −14,295 | $66.03 | $944K | 134,156 |
| 2024-11-12 | Guyer Charles Greg EVP, Chief Technical Officer | Sale | −5,278 | $66.37 | $350K | 68,909 |
| 2024-10-31 | Hardy Alexander Chief Executive Officer | Grant or award | +300 | $56.01 | $17K | 148,451 |
| 2024-10-31 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +55 | $56.01 | $3K | 74,187 |
| 2024-09-30 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award | +21,190 | 21,190 | ||
| 2024-09-30 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award | +7,870 | 29,060 | ||
| 2024-09-30 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +49,850 | 49,850 | ||
| 2024-09-13 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −12,098 | $84.90 | $1.0M | 185,074 |
| 2024-08-13 | Burkhart Erin GVP, Chief Accounting Officer | Sale 10b5-1 | −714 | $90.00 | $64K | 14,449 |
| 2024-06-28 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −588 | $82.33 | $48K | 71,571 |
| 2024-06-03 | HERON ELAINE J Director | Option exercise | +5,047 | $63.10 | $318K | 101,888 |
| 2024-06-03 | HERON ELAINE J Director | Shares withheld for taxes | −4,168 | $76.41 | $318K | 97,720 |
| 2024-06-03 | HERON ELAINE J Director | Option exercise · Stock Option (Right to Buy Common Stock) | −5,047 | 0 | ||
| 2024-06-03 | MEIER RICHARD A Director | Option exercise | +6,600 | $63.10 | $416K | 126,227 |
| 2024-06-03 | MEIER RICHARD A Director | Shares withheld for taxes | −5,451 | $76.41 | $417K | 120,776 |
| 2024-06-03 | MEIER RICHARD A Director | Option exercise · Stock Option (Right to Buy Common Stock) | −6,600 | 0 | ||
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Option exercise 10b5-1 | +5,000 | $63.10 | $316K | 77,159 |
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Sale 10b5-1 | −5,000 | $75.19 | $376K | 72,159 |
Page 6 of 10 · 187 trades